Pfizer Inc. (NYSE: PFE) Q2 2021 Earnings call dated Jul. 28, 2021
Corporate Participants:
Christopher Stevo — Senior Vice President, Chief Investor Relations Officer
Albert Bourla — Chairman and Chief Executive Officer
Mikael Dolsten — Chief Scientific Officer and President, Worldwide Research, Development and Medical
Frank DAmelio — Chief Financial Officer
Angela Hwang — Group President, Pfizer Biopharmaceuticals Group
Analysts:
Kerry Holford — Berenberg — Analyst
Matthew Harrison — Morgan Stanley — Analyst
Daniel Bisbee — RBC Capital — Analyst
Chris Schott — J.P. Morgan — Analyst
Ronny Gal — Bernstein — Analyst
Geoff Meacham — Bank of America — Analyst
Andrew Baum — Citi — Analyst
Carter Gould — Barclays — Analyst
Geoffrey Porges — SVB Leerink — Analyst
Louise Chen — Cantor — Analyst
Terence Flynn — Goldman Sachs — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
BLK Q4 Preview: BlackRock appears poised for another earnings beat
BlackRock, Inc. (NYSE: BLK), the largest asset management company, is expected to publish its fourth-quarter 2025 results next week. The update is expected to shed light on how the firm’s
A look at Best Buy’s (BBY) progress on its growth strategy
Shares of Best Buy Co., Inc. (NYSE: BBY) fell over 3% on Wednesday. The stock has dropped 17% over the past 12 months. The consumer electronics retailer delivered sales and
Citigroup set to report Q4 2025 earnings. Here’s what to expect
Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the
Listen On
